Anamar AB
Patent Applications and Registrations
Patent applications and USPTO patent grants for Anamar AB.The latest application filed is for "new tricyclic 5-ht2 antagonists".
- Anamar AB - Stockholm SE
- ANAMAR AB - Goleborg SE
- AnaMar AB - Gothenburg N/A SE
- AnaMar AB - Goteborg SE
- AnaMar AB - SE SE
Trademarks
| Patent | Date |
|---|---|
| New Tricyclic 5-ht2 Antagonists App 20220267268 - Pettersson; Lars | 2022-08-25 |
| 5-HT2 antagonists Grant 10,544,103 - Pettersson Ja | 2020-01-28 |
| Novel 5-ht2 Antagonists App 20180155292 - PETTERSSON; Lars | 2018-06-07 |
| Metabolic Profiles App 20160018407 - LUNDSTEDT; Erik Torbjorn ; et al. | 2016-01-21 |
| Method of treating inflammation Grant 9,227,927 - Lundstedt , et al. January 5, 2 | 2016-01-05 |
| Determining Pathological Cartilage Turnover App 20150301065 - Lorenzo; Pilar ; et al. | 2015-10-22 |
| Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions Grant 8,663,944 - Lorenzo , et al. March 4, 2 | 2014-03-04 |
| Diagnosis of collagen IX destruction Grant 8,580,529 - Danfelter , et al. November 12, 2 | 2013-11-12 |
| Method Of Treating Inflammation App 20130295009 - LUNDSTEDT; Torbjorn ; et al. | 2013-11-07 |
| Method for treating arthritis Grant 8,410,174 - Lundstedt , et al. April 2, 2 | 2013-04-02 |
| Aminoguanidines as melanocortin receptor ligands Grant 8,372,878 - Lundstedt , et al. February 12, 2 | 2013-02-12 |
| Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Grant 8,309,609 - Lundstedt , et al. November 13, 2 | 2012-11-13 |
| Amides acting on the adenosine receptors Grant 8,227,502 - Lundstedt , et al. July 24, 2 | 2012-07-24 |
| Method For Treating Arthritis App 20120178820 - LUNDSTEDT; Torbjorn ; et al. | 2012-07-12 |
| Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands Grant 8,148,429 - Lundstedt , et al. April 3, 2 | 2012-04-03 |
| Monoclonal antibodies for cartillage oligomeric matrix protein Grant 8,110,663 - Heinegard February 7, 2 | 2012-02-07 |
| Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation Grant 7,956,047 - Aspberg , et al. June 7, 2 | 2011-06-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 